#CongestiveHeartFailure #Pharmacology #LoopDiuretic #ACEInhibiors #BetaBlockers #CardiacGlycosides #Vasodilators #ARBs #Doctor #medical #CHF To view or add a comment, sign in Weight-loss drug reduces heart risks The weight-loss drug semaglutide, found in Wegovy and Ozempic, cuts the risk of cardiovascular problems such as heart attack or stroke, regardless of how much weight people lose, according to a new study published in the Lancet
This characteristic makes it particularly valuable for body composition optimization during fat-loss phases
Notably, liraglutide has demonstrated cardiovascular benefit in high-risk diabetes patients (LEADER trial) and is now regarded as cardioprotective
Crypto checkout was easy after first go
Key Policy: BALANCE and Bridge To understand where Medicare GLP-1 coverage is headed, you need to understand two programs: Bridge and BALANCE
Gala GLP-1 Best User Experience 4.2/5 #6